Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Bladder cancer is not a rare disease. It is one of the 10 most common cancers in the UK and the 5th most common cancer in the European Union.
Read Full NewsFor children hospitalized with migraine, gabapentin use wasn’t associated with less pain or fewer readmissions than no use in an observational study.
Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.
Interpret findings with caution, but AI-based radiomics may help curb unnecessary procedures.
The CQC's 2025 survey of 58,000 patients found rising satisfaction overall, but discharge planning remains an area of difficulty.
For patients with resectable pancreatic cancer, adding radiotherapy to neoadjuvant chemotherapy may improve pathological response, but that doesn’t translate into better outcomes.
Sulfide overproduction in the gut can alter small bowel gene expression more than bacterial or methanogen overgrowth does, affecting mitochondrial function, redox balance, and immune signaling.
Patients referred via a specialized screening clinic that expedites rheumatoid arthritis diagnosis have lower functional disability than those referred via standard referral pathways.
1.
New research uncovers link between cancer pathway and blood-retina barrier function
2.
Novel Psychedelic Promising on Resistant Depression
3.
Getting More Done With Less Blood.
4.
Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC
5.
How wildfires pose challenges to cancer care
1.
Bone Marrow Functional Reserve Screening in Healthy Aging
2.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
3.
Uncovering the Secrets of CA19-9: A Blood Test for Cancer Diagnosis
4.
Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection
5.
The Science Behind Imatinib: How It Targets Cancer Cells
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Expert Perspectives on Hematology
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge